Relationship between serum neutrophil gelatinase-associated lipocalin levels and cognitive impairment, anxiety, and depressive symptoms in acute ischemic stroke

Table 1 Baseline characteristics of the study population stratified by the presence or absence of cognitive impairment, anxiety, and depressive symptoms

Characteristic	Cognitive impairment		P value	Anxiety		P value	Depressive symptoms		P value
	Yes (n = 52)	No (n = 98)		Yes (n = 42)	No (n = 108)		Yes (n = 48)	No (n = 102)
Age, year, mean ± SD	68.3 ± 9.5	63.8 ± 10.3	0.010	66.9 ± 9.8	64.8 ± 10.3	0.261	67.5 ± 9.6	64.4 ± 10.3	0.083
Male, n (%)	28 (53.8)	59 (60.2)	0.448	22 (52.4)	65 (60.2)	0.379	25 (52.1)	62 (60.8)	0.312
BMI, kg/m2, mean ± SD	24.8 ± 3.2	24.3 ± 3.1	0.356	24.5 ± 3.3	24.5 ± 3.1	0.980	24.6 ± 3.2	24.4 ± 3.1	0.720
Smoking, n (%)	18 (34.6)	30 (30.6)	0.614	15 (35.7)	33 (30.6)	0.540	17 (35.4)	31 (30.4)	0.534
Hypertension, n (%)	37 (71.2)	61 (62.2)	0.273	29 (69.0)	69 (63.9)	0.548	33 (68.8)	65 (63.7)	0.544
Diabetes, n (%)	19 (36.5)	28 (28.6)	0.311	15 (35.7)	32 (29.6)	0.472	18 (37.5)	29 (28.4)	0.262
Dyslipidemia, n (%)	28 (53.8)	46 (46.9)	0.415	22 (52.4)	52 (48.1)	0.639	25 (52.1)	49 (48.0)	0.637
Previous stroke, n (%)	10 (19.2)	14 (14.3)	0.417	8 (19.0)	16 (14.8)	0.522	9 (18.8)	15 (14.7)	0.523
NIHSS score at admission, median (interquartile range)	8 (5-12)	5 (3-9)	0.001	7 (4-11)	6 (3-9)	0.118	8 (4-12)	5 (3-9)	0.007

BMI: Body mass index; NIHSS: National Institutes of Health Stroke Scale.